Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolation of the reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
28
Frequently Asked Questions
What is Market Cap of Oncolytics Biotech, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Oncolytics Biotech, Inc. market cap is $106.38M.
What is the 52-week high for Oncolytics Biotech, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Oncolytics Biotech, Inc. 52 week high is $1.53 as of September 07, 2025.
What is the 52-week low for Oncolytics Biotech, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Oncolytics Biotech, Inc. 52 week low is $0.3258 as of September 07, 2025.
What is Oncolytics Biotech, Inc. stock price today?
Oncolytics Biotech, Inc. stock price today is $1.06.
What was Oncolytics Biotech, Inc. stock price yesterday?
Oncolytics Biotech, Inc. stock price yesterday was $1.08.
What is the PE ratio of Oncolytics Biotech, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Oncolytics Biotech, Inc.’s P/E ratio is -3.95.
What is the Price-to-Book ratio of Oncolytics Biotech, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Oncolytics Biotech, Inc. P/B ratio is 23.1391.
What is the 50-day moving average of Oncolytics Biotech, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Oncolytics Biotech, Inc. 50-day moving average is $1.03.
How many employess does Oncolytics Biotech, Inc. has?
